| T lymphocyte-directed gene therapy for ADA− SCID: initial trial results after 4 years RM Blaese, KW Culver, AD Miller, CS Carter, T Fleisher, M Clerici, ... Science 270 (5235), 475-480, 1995 | 2195 | 1995 |
| Inflammatory cytokines in cystic fibrosis lungs. TL Bonfield, JR Panuska, MW Konstan, KA Hilliard, JB Hilliard, H Ghnaim, ... American journal of respiratory and critical care medicine 152 (6), 2111-2118, 1995 | 921 | 1995 |
| Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and … JS Orange, EM Hossny, CR Weiler, M Ballow, M Berger, FA Bonilla, ... Journal of Allergy and Clinical Immunology 117 (4), S525-S553, 2006 | 749 | 2006 |
| Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. MW Konstan, KA Hilliard, TM Norvell, M Berger American journal of respiratory and critical care medicine 150 (2), 448-454, 1994 | 645 | 1994 |
| Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. TL Bonfield, MW Konstan, P Burfeind, JR Panuska, JB Hilliard, M Berger American journal of respiratory cell and molecular biology 13 (3), 257-261, 1995 | 460 | 1995 |
| Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. M Berger, J O'Shea, AS Cross, TM Folks, TM Chused, EJ Brown, ... The Journal of clinical investigation 74 (5), 1566-1571, 1984 | 457 | 1984 |
| Current understanding of the inflammatory process in cystic fibrosis: onset and etiology MW Konstan, M Berger Pediatric pulmonology 24 (2), 137-142, 1997 | 408 | 1997 |
| Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. MF Tosi, H Zakem, M Berger The Journal of clinical investigation 86 (1), 300-308, 1990 | 359 | 1990 |
| Altered respiratory epithelial cell cytokine production in cystic fibrosis TL Bonfield, MW Konstan, M Berger Journal of Allergy and Clinical Immunology 104 (1), 72-78, 1999 | 331 | 1999 |
| The role of inflammation in the pathophysiology of CF lung disease JF Chmiel, M Berger, MW Konstan Clinical reviews in allergy & immunology 23, 5-27, 2002 | 330 | 2002 |
| Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase Y Levy, MS Hershfield, C Fernandez-Mejia, SH Polmar, D Scudiery, ... The Journal of pediatrics 113 (2), 312-317, 1988 | 280 | 1988 |
| Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. M Berger, RU Sorensen, MF Tosi, DG Dearborn, G Döring The Journal of clinical investigation 84 (4), 1302-1313, 1989 | 276 | 1989 |
| Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases HD Ochs, S Gupta, P Kiessling, U Nicolay, M Berger, ... Journal of clinical immunology 26, 265-273, 2006 | 275 | 2006 |
| Subcutaneous immunoglobulin replacement in primary immunodeficiencies M Berger Clinical immunology 112 (1), 1-7, 2004 | 246 | 2004 |
| Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home U Nicolay, P Kiessling, M Berger, S Gupta, L Yel, CM Roifman, A Gardulf, ... Journal of clinical immunology 26, 65-72, 2006 | 225 | 2006 |
| The interference of T cell activation by calcium channel blocking agents. DL Birx, M Berger, TA Fleisher Journal of immunology (Baltimore, Md.: 1950) 133 (6), 2904-2909, 1984 | 210 | 1984 |
| Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency M Berger Immunology and allergy clinics of North America 28 (2), 413-437, 2008 | 186 | 2008 |
| Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease S Jolles, JS Orange, A Gardulf, MR Stein, R Shapiro, M Borte, M Berger Clinical & Experimental Immunology 179 (2), 146-160, 2015 | 179 | 2015 |
| Chronic inflammation in the cystic fibrosis lung: alterations in inter-and intracellular signaling D Nichols, J Chmiel, M Berger Clinical reviews in allergy & immunology 34, 146-162, 2008 | 179 | 2008 |
| Parthenolide inhibits IκB kinase, NF-κB activation, and inflammatory response in cystic fibrosis cells and mice A Saadane, S Masters, J DiDonato, J Li, M Berger American journal of respiratory cell and molecular biology 36 (6), 728-736, 2007 | 178 | 2007 |
